Traws Pharma, Inc. - Director's Dealing 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: MEHTA VIREN (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	C	73839	—	Acquired	85479	Direct
2013-07-30	Common Stock	C	7686	—	Acquired	93165	Direct
2013-07-30	Common Stock	C	17082	—	Acquired	110247	Direct
2013-07-30	Common Stock	P	16667	$15	Acquired	126914	Direct
2013-07-30	Common Stock	C	6768	—	Acquired	6768	Indirect
2013-07-30	Common Stock	C	772	—	Acquired	7540	Indirect
2013-07-30	Common Stock	C	755	—	Acquired	8295	Indirect
2013-07-30	Common Stock	C	4632	—	Acquired	4632	Indirect
2013-07-30	Common Stock	C	1702	—	Acquired	6334	Indirect
2013-07-30	Common Stock	C	1722	—	Acquired	8056	Indirect
2013-07-30	Common Stock	C	1050	—	Acquired	1050	Indirect
2013-07-30	Common Stock	C	345	—	Acquired	1395	Indirect
2013-07-30	Common Stock	C	338	—	Acquired	1733	Indirect

Date	Security	Exercise Price	Code	Shares	A/D	Underlying	Ownership
2013-07-30	Series B Convertible Preferred Stock	$	C	87470	Disposed	Common Stock (73839)	Direct
2013-07-30	Series E Convertible Preferred Stock	$	C	10246	Disposed	Common Stock (7686)	Direct
2013-07-30	Series I Convertible Preferred Stock	$	C	22771	Disposed	Common Stock (17082)	Direct
2013-07-30	Series B Convertible Preferred Stock	$	C	8020	Disposed	Common Stock (6768)	Indirect
2013-07-30	Series C Convertible Preferred Stock	$	C	1030	Disposed	Common Stock (772)	Indirect
2013-07-30	Series D Convertible Preferred Stock	$	C	1007	Disposed	Common Stock (755)	Indirect
2013-07-30	Series B Convertible Preferred Stock	$	C	5488	Disposed	Common Stock (4632)	Indirect
2013-07-30	Series C Convertible Preferred Stock	$	C	2270	Disposed	Common Stock (1702)	Indirect
2013-07-30	Series D Convertible Preferred Stock	$	C	2296	Disposed	Common Stock (1722)	Indirect
2013-07-30	Series B Convertible Preferred Stock	$	C	1245	Disposed	Common Stock (1050)	Indirect
2013-07-30	Series C Convertible Preferred Stock	$	C	460	Disposed	Common Stock (345)	Indirect
2013-07-30	Series D Convertible Preferred Stock	$	C	451	Disposed	Common Stock (338)	Indirect

F1: The Series B Convertible Preferred Stock converted into Common Stock on a 0.85-for-1 basis and had no expiration date.

F2: Includes 11,356 shares held jointly with spouse.

F3: The reporting person is a trustee of the Viram Foundation

F4: The reporting person is managing member of Mehta Partners LLC

F5: The reporting person is trustee of Mehta Partners LLC FBO Jean Kiss Marie IRA.

F6: The Series C Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F7: The Series D Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F8: The Series E Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F9: The Series I Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F10: Includes 17,082 shares held jointly with spouse.

F11: Includes 13,454 shares held jointly with spouse.

F12: Shares held jointly with spouse.